Open Access<p>Plasma Interleukin-37 is Elevated in Acute Ischemic Stroke Patients and Probably Associated With 3-month Functional Prognosis </p>
Author(s) -
Feng Zhang,
Tianrui Zhu,
Heng Li,
Yi He,
Yuanyuan Zhang,
Nana Huang,
Guitao Zhang,
Yanshuang Li,
Dujuan Chang,
Xiaohong Li
Publication year - 2020
Publication title -
clinical interventions in aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 76
eISSN - 1178-1998
pISSN - 1176-9092
DOI - 10.2147/cia.s230186
Subject(s) - medicine , modified rankin scale , odds ratio , stroke (engine) , confidence interval , interleukin 6 , gastroenterology , interleukin , brain ischemia , inflammation , cytokine , ischemic stroke , ischemia , mechanical engineering , engineering
Interleukin-37 is a novel cytokine emerging as a natural suppressor of inflammatory responses. Inflammation and the immune response play important roles in acute ischemic stroke. This study aimed at evaluating the plasma levels and the association with 3-month outcomes of interleukin-37 in acute ischemic stroke patients.